Karyopharm Therapeutics Inc. (KPTI) Social Stream
KARYOPHARM THERAPEUTICS INC (KPTI) Price Targets From Analysts
Use the tables below to see what analysts covering KARYOPHARM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 8 | $35 | $6 | $17.714 | $2.5 | 608.56% |
| 2021-11-19 | 8 | $35 | $6 | $15.285 | $2.5 | 511.4% |
| 2021-12-21 | 8 | $35 | $6 | $15.571 | $2.5 | 522.84% |
| 2022-02-01 | 8 | $35 | $8 | $16 | $2.5 | 540% |
| 2022-02-09 | 8 | $35 | $8 | $16.428 | $2.5 | 557.12% |
| 2022-03-02 | 8 | $35 | $6 | $14.75 | $2.5 | 490% |
| 2022-03-18 | 8 | $35 | $6 | $14.625 | $2.5 | 485% |
| 2022-04-12 | 7 | $22 | $6 | $11.714 | $2.5 | 368.56% |
| 2022-05-06 | 7 | $22 | $6 | $11.5 | $2.5 | 360% |
| 2022-07-14 | 7 | $21 | $5 | $10.875 | $2.5 | 335% |
| 2022-08-04 | 9 | $18 | $5 | $10.5 | $2.5 | 320% |
| 2022-08-05 | 8 | $18 | $5 | $10.1 | $2.5 | 304% |
| 2022-10-20 | 8 | $18 | $5 | $9.8 | $2.5 | 292% |
| 2022-11-04 | 9 | $18 | $5 | $9.9 | $2.5 | 296% |
| 2022-12-13 | 9 | $18 | $5 | $9.7 | $2.5 | 288% |
| 2023-01-10 | 9 | $16 | $5 | $9.3 | $2.5 | 272% |
| 2023-01-19 | 10 | $16 | $5 | $9.181 | $2.5 | 267.24% |
| 2023-02-15 | 9 | $16 | $5 | $9 | $2.5 | 260% |
| 2023-03-30 | 10 | $16 | $5 | $9.4 | $2.5 | 276% |
| 2023-04-19 | 10 | $16 | $5 | $9.444 | $2.5 | 277.76% |
| 2023-05-04 | 10 | $16 | $5 | $9 | $2.5 | 260% |
| 2023-05-08 | 10 | $14 | $5 | $8.1 | $2.5 | 224% |
The Trend in the Analyst Price Target
Over the past 25 months, KPTI's average price target has gone down $22.3.
Over the past 49 weeks, KPTI's average upside potential has been 149.71%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-10 | 9 | 16 | 5 | 9.3 | 2.87 | 224.04% |
| 2023-02-01 | 10 | 16 | 5 | 9.0 | 3.34 | 169.46% |
| 2023-02-16 | 10 | 16 | 5 | 9.0 | 3.59 | 150.7% |
| 2023-04-19 | 10 | 16 | 5 | 9.0 | 4.14 | 117.39% |
| 2023-05-08 | 10 | 14 | 5 | 8.1 | 2.50 | 224% |
KPTI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.9 | 5 | 1 | 4 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 16 months, KPTI's average broker recommendation rating improved by 0.6.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how KARYOPHARM THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2542.09% of that group.
- In the context of all US stocks, KARYOPHARM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2528.42% of them.
- KARYOPHARM THERAPEUTICS INC's number of analysts covering the stock is higher than 2600.51% of stocks in the small market cap category.
- In the context of Healthcare stocks, KARYOPHARM THERAPEUTICS INC's average analyst price target is greater than 608.36% of them.
In the Pharmaceutical Products industry, ATOS, NHWK, and TVTX are the three stocks most similar to KARYOPHARM THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding KPTI using the data that counts. Try POWR Ratings for free.